A new study on carbetocin was published on October 12, 2026. The publication is titled "Prophylactic Carbetocin Versus Oxytocin and Blood Loss After Vaginal Delivery: Agent Selection and Confounding by Indication in a Retrospective Cohort Study." It appeared in the journal Medicina (Kaunas, Lithuania).
The study is described as a retrospective cohort study examining agent selection and confounding by indication in relation to carbetocin and oxytocin use after vaginal delivery. No findings, outcomes, or conclusions from the study have been provided alongside this publication record. Carbetocin remains classified as an unapproved compound for research purposes.
This brief reports only the existence and bibliographic details of the publication as listed. No efficacy, safety, or comparative results between carbetocin and oxytocin are stated or implied here. Readers interested in further detail should consult the original publication directly through the source listed.
For more background on this compound, see the compound overview linked with this brief.